[1]
|
H. T. Chana, Y. Y. Doa, P. L. Huang, et al. Preparation and pro- perties of bio-compatible magnetic Fe3O4 nanoparticles. Journal of Magnetism and Magnetic Materials, 2006, 304: e415-e417.
|
[2]
|
Y. J. Lee, K. W. Jun, J. Y. Park, et al. A simple chemical route for the synthesis of γ-Fe2O3 nano-particles dispersed in organic sol- vents via an iron-hydroxy oleate precursor. Journal of Industrial and Engineering Chemistry, 2008, 14(1): 38-44.
|
[3]
|
S. H. Sun, H. Zeng, D. B. Robinson, et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) Nano-particles. Journal of the Amer- ican Chemical Society, 2004, 126(1): 273-279.
|
[4]
|
A. H. Lu, E. L. Salabas and F. Schüth. Magnetic nanoparticles: Synthesis, protection, function-alization and application. Ange- wandte Chemie International Edition, 2007, 46(8): 1222-1244.
|
[5]
|
C. Alexiou, R. J. Schmid, R. Jurgons, et al. Targeting cancer cells: Magnetic nanoparticles as drug carriers. European Bio- physics Journal, 2006, 35(5): 446-450.
|
[6]
|
N. Tobias. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. Journal of Magnetism and Magnetic Materials, 2005, 293(1): 483-496.
|
[7]
|
J. Dobson. Magnetic nanoparticles for drug delivery. Drug De-velopment Research, 2006, 67: 55.
|
[8]
|
A. E. Senyei, K. J. Widder. Drug targeting: Magnetically re- sponsive albumin microspheres—A review of the system to date. Gynecologic Oncology, 1981, 12(1): 1-13.
|
[9]
|
A. S. Lübbe, C. Bergemann, J. Brock, et al. Physiologicalaspects in magnetic drug targeting. Journal of Magnetism and Magnetic Materials, 1999, 194(1): 149-155.
|
[10]
|
A. S. Lübbe, C. Alexiou and C. Bergemann. Clinical applica- tions of magnetic drug targeting. Journal of Surgical Research, 2001, 95(2): 200-206.
|
[11]
|
C. Alexiou, W. Arnold, R. J. Klein, et a1. Locoregional cancer treatment with magnetic drug targeting. Cancer Research, 2000, 60(23): 6641-6648.
|
[12]
|
任非, 陈建良, 陈志良等. MMC聚氰基丙烯酸正丁酯磁性纳米球对BEL-7402人肝癌细胞裸小鼠移植瘤的作用[J]. 第四军医大学学报, 2005, 16(26): 1510-1512.
|
[13]
|
E. Munnier, S. Cohen-Jonathan, C. Linassier, et al. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting. International Journal of Pharmaceutics, 2008, 363(1-2): 170-176.
|
[14]
|
K. J. Widder, A. E. Senyer, D. G. Scarpelli, et al. Magnetic mi- crospheres: A model system for site specific drug delivery in vivo. Proceedings of the Society for Experimental Biology and Medicine, 1978, 158(2): 141-146.
|
[15]
|
常津. 具有靶向抗癌功能的纳米高分子材料-阿霉素免疫磁性毫微粒的体内磁靶向定位实验[J]. 中国生物医学工程学报, 1996, 15(4): 354-359.
|
[16]
|
M. Babincova, V. Altanerova, M. Lampert, et al. Site-specific in vivo targeting of magneto-liposomes using externally applied magnetic field. Zeitschrift Naturforschung, 2000, 55(3-4): 278- 281.
|
[17]
|
S. Goodwin, C. Peterson, C. Hoh, et al. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. Journal of Magnetism and Magnetic Materials, 1999, 194(1-3): 132-139.
|
[18]
|
曹金全, 汪勇先, 于俊峰等. 磁性纳米微粒的188Re标记[J]. 同位素, 2004, 17(2): 84-89.
|
[19]
|
U. Häfeli, G. Pauer, S. Failing, et al. Radiolabeling of magnetic particles with rhenium-188 for cancer therapy. Journal of Mag- netism and Magnetic Materials, 2001, 225(1-2): 73-78.
|
[20]
|
P. Wust, B. Hildebrandt, G. Sreenivasa, et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology, 2002, 3(8): 487-497.
|
[21]
|
R. Langer, J. L. Cleland and J. Hanes. New advances in micro- sphere-based single-dose vaccines. Advanced Drug Delivery Reviews, 1998, 28(1): 97-119.
|
[22]
|
U. O. Häfeli. Magnetically modulated therapeutic systems. In- ternational Journal of Pharmaceutics, 2004, 277(1-2): 19.
|
[23]
|
R. K. Gilchrist, R. Medal, W. D. Shorey, et al. Selective induc- tive heating of lymph nodes. Annals of Surgery, 1957, 146: 596- 606.
|
[24]
|
A. Jordan, R. Scholz, P. Wust, et al. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. In- ternational Journal of Hyperthermia, 1997, 13(6): 587-605.
|
[25]
|
M. Yanase, M. Shinkai, H. Honda, et al. Intracellular hyperther- mia for cancer using magnetite cationic liposomes: An in vitro study. Japanese Journal of Cancer Research, 1996, 89(4): 463- 469.
|
[26]
|
A. Jordan, R. Scholz, K. Maoer-Hauff, et al. The effect of ther- motherapy using magnetic nanoparticles on rat malignant glioma. Journal of Neuro-Oncology, 2006, 78(1): 7-14.
|
[27]
|
S. Wada, L. Yue, K. Tazawak, et al. New local hypertherm ia using dextran magnetite complex (DM) for oral cavity experi- mental study in normal hamster tongue. Oral Diseases, 2001, 7(3): 192-195.
|
[28]
|
S. Wada, K. Tazawak, I. Furuta, et al. Antitumor effect of new local hypertherm is using dextran magnetite complex in hamster tongue carcinoma. Oral Diseases, 2003, 9(4): 218-223.
|
[29]
|
A. K. Guptaa, M. Gupta. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomate- rials, 2005, 26(18): 3995-4021.
|
[30]
|
T. L. Andresen, S. S. Jensen and K. Jorgensen. Advanced strate- gies in liposomal cancer therapy: Problems and prospects of ac- tive and tumor specific drug release. Progress in Lipid Research, 2005, 44(1): 68-97.
|
[31]
|
I. Takahashi, Y. Emi, S. Hasuda, et al. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery, 2002, 131(1): S78-S84.
|
[32]
|
M. Xu, R. J. Myerson, C. Hunt, et al. Transfection of human tumour cells with siRNA and the increase in radiation sensitivity and the reduction in heat-induced radiosensitization. Interna- tional Journal of Hyperthermia, 2004, 20(2): 157-162.
|
[33]
|
M. Xu, R. J. Myerson, W. L. Straube, et al. Radiosensitization of heat resistant human tumour cells by 1 hour at 41.1 degrees C and its effect on DNA repair. International Journal of Hyper- thermia, 2002, 18(5): 385-403.
|
[34]
|
F. Zolzer, C. Strefer. G2-phase delays after irradiation and/or heat treatment as assessed by two-parameter flow cytometry. Radia- tion Research, 2001, 155(1): 50-56.
|
[35]
|
K. E. Scarberry, E. B. Dickerson, J. F. McDonald, et al. Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells. Journal of the American Chemical Society, 2008, 130(31): 10258-10262.
|
[36]
|
Y. Sawaji, T. Sato, A. Taakeuchi, et al. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. British Journal of Cancer, 2002, 86(10): 1597-1603.
|
[37]
|
X. T. Meng, H. C. Seton, L. T. Lu, I. A. Prior, et al. Magnetic CoPt nanoparticles as MRI contrast agent for transplanted neural stem cells detection. Nanoscale, 2011, 3(3): 977-984.
|